Redox-dependent MAP kinase signaling by Ang II in vascular smooth muscle cells: Role of receptor tyrosine kinase transactivation

Canadian Journal of Physiology and Pharmacology

Volumn 81, Issue 2, 2003, Pages 159-167

  Touyz, Rhian M ^a   Cruzado, Montserrat ^a   Tabet, Fatiha ^a   Yao, Guoying ^a   Salomon, Steven ^a   Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

EGFR; ERK1 2; IGF 1R; p38MAP kinase; Signal transduction

Indexed keywords

3 BROMO 5 TERT BUTYL 4 HYDROXYBENZYLIDENEMALONONITRILE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ACETOACETIC ACID; ANGIOTENSIN; DICHLORODIHYDROFLUORESCEIN DIACETATE; DIPHENYLIODONIUM SALT; EPIDERMAL GROWTH FACTOR RECEPTOR; LUCIGENIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; SOMATOMEDIN C RECEPTOR; TIRON; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; BIOAVAILABILITY; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FLUORESCENCE; IMMUNOBLOTTING; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

EID: 0037306526     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y02-164     Document Type: Conference Paper

References (48)

1. Abe, J-I., Kusuhara, M., Ulevitch, R.J., Berk, B.C., and Lee, J-D. 1996. Big Mitogen-activated protein kinase 1 (BMK1) is a redox-sensitive kinase. J. Biol. Chem. 271(28): 16 586 - 16 590.
2. Abe, J.I, Takahashi, M., Ishida, M., Lee, J-D., and Berk, B.C. 1997. C-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1). J. Biol. Chem. 272: 20 389 - 20 394.
3. Aikawa, R., Komuro, I., Yamazaki, T., Zou, Y., Kudoh, S., Tanaka, M., Shiojima, I., Hiroi, I., and Yazaki, Y. 1997. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J. Clin. Invest. 100: 1813-1821.
4. - in vascular smooth muscle cells. Circ. Res. 77: 29-36.
5. Babior, B.M. 1999. NADPH oxidase: an update. Blood, 93(5): 1464-1476.
6. Bae, Y.S., Kang, S.W., Seo, M.S., Baines, I.C., Tekle, E., Chock, P.B., and Rhee, S.G. 1997. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272: 217-221.
7. Berk, B.C. 1999. Redox signals that regulate the vascular response to injury. Thromb. Haemost. 82(2): 810-7.
8. Davies, S.P., Reddy, H., Caivano, M., and Cohen, P. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351: 95-105.
9. Droge, W. Free radicals in the physiological control of cell function. 2001. Physiol. Rev. 82: 47-95.
10. Eguchi, S., Iwasaki, H., Hirata, Y., Frank, G.D., Motley, E.D., Yamakawa, T., Numaguchi, K., and Inagami, T. 1999. Epidermal growth factor receptor is indispensable for c-fos expression and protein synthesis by angiotensin II. Eur. J. Pharmacol. 376: 203-206.
11. Eguchi, S., and Inagami, T. 2000. Signal transduction of angiotensin II type I receptor through receptor tyrosine kinase. Regul. Pept. 91: 13-20.
12. Eguchi, S., Numaguchi, K., Iwasaki, H., Matsumoto, T., Yamakawa, T., Utsunomiya, H., Motley, E.D., Kawakatsu, H., Owada, K.M., Hirata, Y., Marumo, F., and Inagami, T. 1998. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273(15): 8890-8896.
13. English, J.M., Pearson, G., Hockenberry, T., Shivakumar, L., White, M.A., and Cobb, M.H. 1999. Contribution of the ERK5/MEK5 pathway to Ras/Raf signalling and growth control. J. Biol. Chem. 274(44): 31 588 - 31 592.
14. Griendling, K.K., Minieri, C.A., Ollerenshaw, J.D., Alexander, R.W. 1994. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 74: 1141-1148.
15. Griendling, K.K., Sorescu, D., Lassegue, B., and Ushio-Fukai, M. 2000. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20: 2175-2183.
16. Griendling, K.K., Sorescu, D., and Ushio-Fukai, M. NADPH oxidase. Role in cardiovascular biology and disease. 2000. Circ. Res. 86:494-501.
17. Hannken, T, Schroeder, R., Zahner, G., Stahl, R.A., and Wolf, G. 2000. Reactive oxygen species stimulate p44/p42 mitogen-activated protein kinase and inducer p27(Kip1): role in angiotensin II-mediated hypertrophy of proximal tubular cells. J. Am. Soc. Neph. 11(8): 1387-1397.
18. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, and Tamaki T. 2001. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens. Res. 24(3): 251-261.
19. Lounsbury, K,M, Hum, Q, and Ziegelstein, R.C. 2000. Calcium signaling and oxidant stress in the vasculature. Free Rad. Biol. Med. 28(9): 1362-1369.
20. Nicol, R.L., Frey, N., Pearson, G., Cobb, M., Richardson, J., and Olson, E.N. 2001. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO, 20(11): 2757-2767.
21. Pearson, G., English, J.M., White, M.A., and Cobb, M.H. 2001. ERK5 and ERK2 cooperate to regulate NF-kappa B and cell transformation. J. Biol. Chem. 276(11): 7927-7931.
22. Pearson, G., Robinson, F., Beers Gibson, T., Xu, B-E., Karandikar, M., Berman, K., and Cobb, M.H. 2001. Mitogen-activated protein kinase pathways: regulation and physiological functions. Endoc. Rev. 22(2):153-183.
23. Saito, Y., and Berk, B.C. 2001. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors. J. Mol. Cell Cardiol. 33: 3-7.
24. Shah B.H. 2002. Epidermal growth factor receptor transactivation in angiotensin II-induced signaling: role of cholesterol-rich microdomains. Trends Endoc. Metab. 13(1) : 1-3
25. Skatchkov, M.P.S., and Meinertz, T.M. 1999. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem. Biophys. Res. Commun. 254: 319-324.
26. Su, B., Mitra, S., Gregg, H., Flavahan, S., Chotani, M.A., Clark, K.R, Goldschmidt-Clermont, P.J., and Flavahan, N.A. 2001. Redox regulation of vascular smooth muscle cell differentiation. Circ. Res. 89: 39-46.
27. 2 for platelet derived growth factor signal transduction. Science, 270: 296-299.
28. Thannickal, V.J., and Fanburg, B.L. 2000. Reactive oxygen species in cell signalling. Am. J. Physiol. 279: L1005-L1028.
29. Thomas, W.G., Brandednburger, Y., Autelitano, D.J, Pham, T., Qian, H., and Hannan, R.D. 2002. Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor. Circ. Res. 90: 135-142.
30. Touyz, R.M. 2000. Oxidative stress and vascular damage in hypertension. Curr Hypert Rep. 2: 98-105.
31. Touyz, R.M., and Schiffrin, E.L. 1999. Ang II-stimulated generation of reactive oxygen species in human vascular smooth muscle cells is mediated via PLD-dependent pathways. Hypertension, 34(part 2): 976-982.
32. Touyz, R.M., and Schiffrin, E.L. 2001. Increased generation of superoxide by angiotensin II is mediated via PLD-dependent, NADPH oxidase-sensitive pathways in vascular smooth muscle cells from hypertensive patients. J. Hyperten. 19(7): 1245-1254.
33. 2+ responses to angiotensin II but not to endothelin-1. J. Hypertens. 12: 663-673.
34. Touyz, R.M., Deng, L-Y., He, G., Schiffrin, E.L. 1999. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human peripheral resistance arteries - role of extracellular signal-regulated kinases. J. Hyperten. 17(7): 907-917.
35. Touyz, R.M., He, G., Deng, L.Y., and and Schiffrin, E.L. 1999. Role of extracellular signal-regulated kinases in Angiotensin II-stimulated contraction of smooth muscle cells from human resistance vessels. Circulation, 99: 392-399.
36. Touyz, R.M., He, G., El Mabrouk, M., Diep, Q., Mardigyan, V., and Schiffrin, E.L. 2001. Differential activation of ERK1/2 and p38MAP kinase by angiotensin II type I receptor in vascular smooth muscle cells from WKY and SHR. J. Hypertens. 19: 553-559.
37. Touyz, R.M., He, G., El Mabrouk, M., Schiffrin, E.L. 2001. P38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension, 37: 574-580.
38. 2+ signaling by angiotensin II in human vascular smooth muscle cells. J. Hypertens. 19: 441-449.
39. Touyz, R.M, Chen, X., He, G., Quinn, M.T, and Schiffrin, E.L. 2002. Expression of a gp91phox-containing leukocyte-type NADPH oxidase in human vascular smooth muscle cells - modulation by Ang II. Circ. Res. 90: 1205-1213.
40. Touyz, R.M., Wu, X-H., He, G., and Schiffrin, E.L. 2002. Increased Ang II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from SHR. Hypertension, 39(2): 479-485.
41. Ushio-Fukai, M., Alexander, R.W., Akers, M., and Griendling, K.K. 1998. P38 MAP kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. J. Biol. Chem. 273:15 022 - 15 029.
42. Ushio-Fukai, M., Alexander, R.W., Akers, M., Yin, Q., Fuijo, Y., Walsh, K., and Griendling, K.K. 1999. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J. Biol. Chem. 274:22 699 - 22 704.
43. Ushio-Fukai, M., Griendling, K.K., Becker, P.L., Hilenski, L., Halleran, S., and Alexander, R.W. 2001. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21: 489-495.
44. Viedt, C., Soto, U., Krieger-Brauer, H.I., Fei, J., Elsing, C., Kubler, W., and Kreuzer, J. 2000. Differential activation of MAP kinases in smooth muscle cells by Ang II. Involvement of p22phox and reactive oxygen species. Arterioscler. Thromb. Vasc. Biol. 20: 940-948.
45. 2+ levels. J. Biol. Chem. 275: 12 223 - 12 230.
46. Wolf, G. 2000. Free radical production and angiotensin. Curr. Hyper. Rep. 2: 167-173.
47. 2 in angiotensin II-induced vascular hypertrophy. Hypertension, 32: 488-495.
48. Zalba, G., San, Jose, G., Moreno, M.U., Fortuno, M.A., Fortuna, A., Beaumont, F.J., and Diez, J. 2001. Oxidative stress in arterial hypertension. Role of NADPH oxidase. Hypertension, 38: 1395-1399.